Diselenide crosslinks for enhanced and simplified oxidative protein folding.


Journal

Communications chemistry
ISSN: 2399-3669
Titre abrégé: Commun Chem
Pays: England
ID NLM: 101725670

Informations de publication

Date de publication:
05 Mar 2021
Historique:
received: 06 09 2020
accepted: 29 01 2021
entrez: 25 1 2023
pubmed: 5 3 2021
medline: 5 3 2021
Statut: epublish

Résumé

The in vitro oxidative folding of proteins has been studied for over sixty years, providing critical insight into protein folding mechanisms. Hirudin, the most potent natural inhibitor of thrombin, is a 65-residue protein with three disulfide bonds, and is viewed as a folding model for a wide range of disulfide-rich proteins. Hirudin's folding pathway is notorious for its highly heterogeneous intermediates and scrambled isomers, limiting its folding rate and yield in vitro. Aiming to overcome these limitations, we undertake systematic investigation of diselenide bridges at native and non-native positions and investigate their effect on hirudin's folding, structure and activity. Our studies demonstrate that, regardless of the specific positions of these substitutions, the diselenide crosslinks enhanced the folding rate and yield of the corresponding hirudin analogues, while reducing the complexity and heterogeneity of the process. Moreover, crystal structure analysis confirms that the diselenide substitutions maintained the overall three-dimensional structure of the protein and left its function virtually unchanged. The choice of hirudin as a study model has implications beyond its specific folding mechanism, demonstrating the high potential of diselenide substitutions in the design, preparation and characterization of disulfide-rich proteins.

Identifiants

pubmed: 36697775
doi: 10.1038/s42004-021-00463-9
pii: 10.1038/s42004-021-00463-9
pmc: PMC9814483
doi:

Types de publication

Journal Article

Langues

eng

Pagination

30

Subventions

Organisme : Israel Science Foundation (ISF)
ID : 1072/14
Organisme : Israel Science Foundation (ISF)
ID : 783/18
Organisme : Israel Science Foundation (ISF)
ID : 1905/15
Organisme : Israel Cancer Research Fund (Israel Cancer Research Fund, Inc.)
ID : Acceleration Grant

Informations de copyright

© 2021. The Author(s).

Références

Proteins. 2003 Nov 15;53(3):720-30
pubmed: 14579362
Chemistry. 2020 Apr 9;26(21):4695-4700
pubmed: 31958351
Biochemistry. 2011 May 3;50(17):3414-31
pubmed: 21410235
Angew Chem Int Ed Engl. 2012 Jun 4;51(23):5580-4
pubmed: 22454362
Angew Chem Int Ed Engl. 2008;47(36):6851-5
pubmed: 18651678
Biochemistry. 2007 May 8;46(18):5382-90
pubmed: 17419591
Antioxid Redox Signal. 2013 May 1;18(13):1675-89
pubmed: 23121622
Science. 1994 Nov 4;266(5186):776-9
pubmed: 7973629
Chemistry. 2019 Jun 26;25(36):8513-8521
pubmed: 31012517
Angew Chem Int Ed Engl. 2018 Sep 3;57(36):11634-11639
pubmed: 29908104
Angew Chem Int Ed Engl. 2011 Jul 11;50(29):6527-9
pubmed: 21630402
Science. 1990 Jul 20;249(4966):277-80
pubmed: 2374926
Curr Opin Struct Biol. 2014 Feb;24:81-90
pubmed: 24434632
Bioinformatics. 2015 Apr 15;31(8):1325-7
pubmed: 25505092
J Am Chem Soc. 2001 May 30;123(21):5140-1
pubmed: 11457362
Annu Rev Cell Dev Biol. 2008;24:211-35
pubmed: 18588487
Angew Chem Int Ed Engl. 2016 Jan 18;55(3):992-5
pubmed: 26636774
J Am Chem Soc. 2010 Mar 17;132(10):3514-22
pubmed: 20163143
Biochemistry. 2010 Mar 30;49(12):2741-52
pubmed: 20175537
Biochem J. 1994 Jun 15;300 ( Pt 3):643-50
pubmed: 8010946
Prog Biophys Mol Biol. 1978;33(3):231-97
pubmed: 358273
J Biol Chem. 1992 Feb 15;267(5):3038-43
pubmed: 1737759
Org Lett. 2001 May 3;3(9):1331-4
pubmed: 11348227
J Pept Sci. 2012 Jan;18(1):1-9
pubmed: 22083608
J Biol Chem. 1993 Oct 5;268(28):20988-96
pubmed: 8407935
Chem Sci. 2018 May 2;9(21):4814-4820
pubmed: 29910933
Biochemistry. 2008 Jul 8;47(27):6985-7
pubmed: 18553979
Biochem Biophys Res Commun. 1983 Dec 16;117(2):479-85
pubmed: 6661238
J Mol Biol. 1991 Sep 20;221(2):583-601
pubmed: 1920434
J Mol Biol. 1998 Dec 4;284(3):779-92
pubmed: 9826515
J Biol Chem. 1992 Sep 5;267(25):17670-8
pubmed: 1517214
Angew Chem Int Ed Engl. 2014 Apr 7;53(15):3947-51
pubmed: 24615823
Science. 1973 Jul 20;181(4096):223-30
pubmed: 4124164
J Pept Sci. 2016 Jan;22(1):4-27
pubmed: 26785684
Angew Chem Int Ed Engl. 2017 May 8;56(20):5522-5526
pubmed: 28394477
Chem Rev. 2014 Jan 22;114(2):901-26
pubmed: 24446748
Biochemistry. 1986 Aug 12;25(16):4622-8
pubmed: 3768302
Angew Chem Int Ed Engl. 2017 Dec 11;56(50):15818-15827
pubmed: 28857389
Trends Biochem Sci. 2006 May;31(5):292-301
pubmed: 16600598
Protein Sci. 1999 Aug;8(8):1605-13
pubmed: 10452604
Chem Sci. 2015 Jan 1;6(1):322-325
pubmed: 28757941
Angew Chem Int Ed Engl. 2020 Jul 6;59(28):11218-11232
pubmed: 31867866
Angew Chem Int Ed Engl. 2012 Jun 4;51(23):5585-8
pubmed: 22454335
J Biol Chem. 1995 May 19;270(20):11992-7
pubmed: 7744849
Science. 1991 Sep 20;253(5026):1386-93
pubmed: 1716783
Chem Commun (Camb). 2016 Feb 25;52(16):3336-9
pubmed: 26822519
FEBS Lett. 1990 Sep 17;270(1-2):85-9
pubmed: 2226793
Eur J Biochem. 1991 Nov 15;202(1):67-73
pubmed: 1935981
Chem Soc Rev. 2009 Feb;38(2):338-51
pubmed: 19169452
Curr Opin Chem Biol. 2014 Oct;22:27-34
pubmed: 25261915
J Biol Chem. 1995 Oct 27;270(43):25661-6
pubmed: 7592743

Auteurs

Reem Mousa (R)

Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.

Taghreed Hidmi (T)

Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.

Sergei Pomyalov (S)

Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.

Shifra Lansky (S)

Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.

Lareen Khouri (L)

Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.

Deborah E Shalev (DE)

Department of Pharmaceutical Engineering, Azrieli College of Engineering Jerusalem and Wolfson Centre for Applied Structural Biology, The Hebrew University of Jerusalem, Jerusalem, Israel.

Gil Shoham (G)

Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel. Gil2@mail.huji.ac.il.

Norman Metanis (N)

Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel. Metanis@mail.huji.ac.il.

Classifications MeSH